1
0
0
(1 - 13 von 13
)
Studies on Carboline Anhydronium Bases - ACS PublicationsAmerican Chemical Society
pubs.acs.org
von B Witkop · · Zitiert von: 46 — ... Cornelius Hempel, Frank Totzke, Christoph Schächtele, Abdulkarim Najjar, ... Christoph Schächtele, Frank Totzke, Wolfgang Sippl, Andreas Hilgeroth. › doi › abs
Curriculum Vitae Dr. Kazem MahmoudEgyptian Russian University
www.eru.edu.eg
➢ Volkmar Tell, Max Holzer, Lydia Herrmann, Kazem Ahmed Mahmoud,. Christoph Schächtele, Frank Totzke, Andreas Hilgeroth. Multitargeted drug development: ... › eru-files › PDF › Kaz...
ChemInform Abstract: Multitargeted Drug Development: Discovery and...
www.chemie.de
Autoren: Volkmar Tell, Max Holzer, Lydia Herrmann, Kazem Ahmed Mahmoud, Christoph Schaechtele, Frank Totzke, Andreas Hilgeroth. Journal: ChemInform.
Novel Protein Kinase Inhibitors Related to Tau Pathology ...
pdfs.semanticscholar.org
von M Holzer · Zitiert von: 17 — Valentina Neukel 1, Moritz Oberstadt 3, Frank Totzke 4, Christoph Schächtele 4,. Wolfgang Sippl 2 and Andreas Hilgeroth 2,*. › ...
Discovery of novel dual inhibitors of receptor tyrosine ...National Institutes of Health (.gov)
pubmed.ncbi.nlm.nih.gov
von C Hempel · · Zitiert von: 6 — Cornelius Hempel , Frank Totzke , Christoph Schächtele , Abdulkarim Najjar , Wolfgang Sippl , Christoph Ritter , Andreas Hilgeroth ... › ...
Approaches to a Multitargeting Drug Development: First ...
benthamscience.com
Author(s): Andreas Hilgeroth, Volkmar Tell, Steffi Kramer, Frank Totzke and Christoph Schachtele. Volume 10, Issue 1, Page: [ ] Pages: 8. › article
Effects of Specific Inhibitors for CaMK1D on a Primary ...Researcher App
www.researcher-app.com
... Jens Stieler, Tim Vogel, Isabel Hilbrich, Wolfgang Sippl, Andreas Hilgeroth, Christoph Schächtele, Nico Schade, Valentina Neukel, Frank Totzke. › ...
First Profiled 3- Ethoxycarbonyl-1-aza-9-oxafluorenes ...
www.eurekaselect.com
Author(s): Andreas Hilgeroth, Volkmar Tell, Steffi Kramer, Frank Totzke and Christoph Schachtele. Volume 10, Issue 1, Page: [ ] Pages: 8. › node
Discovery of novel dual inhibitors of receptor PubMed
pubmed.ncbi.nlm.nih.gov
von T Fischer · · Zitiert von: 13 — Authors. Tim Fischer , Abdulkarim Najjar , Frank Totzke , Christoph Schächtele , Wolfgang Sippl , Christoph Ritter , Andreas Hilgeroth ... › ...
Novel aspects in structure–activity relationships of profiled ...Royal Society of Chemistry
pubs.rsc.org
von V Tell · · Zitiert von: 10 — Volkmar Tell,a Kazem Ahmed Mahmoud,a Kanin Wichapong,a Christoph Schächtele,bFrank Totzke,b Wolfgang Sippla and Andreas Hilgeroth*a. Author affiliations. von C Hempel · · Zitiert von: 5 — Cornelius Hempel,a Abdulkarim Najjar,aFrank Totzke,b Christoph Schächtele,b Wolfgang Sippl,a Christoph Ritterc and Andreas Hilgeroth*a. Author affiliations. › articlelanding
Novel Protein Kinase Inhibitors Related to Tau Pathology ...
www.mdpi.com
von M Holzer · · Zitiert von: 17 — Frank Totzke. 4,. Christoph Schächtele. 4,. Wolfgang Sippl. 2 and. Andreas Hilgeroth. 2,*. 1. Department for Molecular and Cellular Mechanisms of ... von B Pinchuk · · Zitiert von: 15 — Frank Totzke. 3 and ... Pinchuk, Boris, Eugen Johannes, Sheraz Gul, Joachim Schlosser, Christoph Schaechtele, Frank Totzke, and Christian Peifer › ...
Stefan Peukert*, Karen Miller-Moslin* Small-Molecule Inhibitors of the ...
application.wiley-vch.de
... Frank Totzke, Andreas Hilgeroth* Discovery of 4-Benzylamino-Substituted α- Carbolines as a Novel Class of Receptor Tyrosine Kinase Inhibitors [Full Paper]
发现新型取代的苯并芳基的4-苄基氨基吡咯并嘧啶作为 X-MOL
www.x-mol.com
Tim Fischer, Thomas Krüger, Abdulkarim Najjar, Frank Totzke, Christoph Schächtele, Wolfgang Sippl, Christoph Ritter, Andreas Hilgeroth ... › paper
Alle Infos zum Namen "Frank Totzke"
sortiert nach Relevanz / Datum